Director Amgen Ventures
Amgen
- Location
- US Massachusetts Cambridge
- Work model
- On-Site
- Level
- Staff
- H-1B history
- 137 approvals (FY2023)
- Posted
- Sep 3, 2026
About this role
Career Category Business Development Job Description Join Amgen’s Mission of Serving Patients At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases, and obesity and obesity-related conditions. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives. Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career. Director Amgen Ventures What you will do Let’s do this. Let’s change the world. Amgen Ventures is the strategic venture capital arm of Amgen, investing in innovative biotechnology companies and venture funds that advance scientific innovation aligned with Amgen’s long-term research and business development priorities. As a Director on the Amgen Ventures team, you will play a key role in sourcing, evaluating, executing, and managing venture investments across therapeutics, technology platforms, and emerging healthcare innovations. Working closely with Research & Development, Business Development, Strategy, Corporate Finance, Legal, and portfolio company leadership, you will help identify opportunities that provide strategic insight, scientific connectivity, and financial returns while helping shape the future of biotechnology.
Responsibilities
Investment Sourcing & Evaluation Identify and evaluate private biotechnology companies, healthcare technology companies, and venture capital funds aligned with Amgen’s strategic and scientific priorities. Maintain active relationships with entrepreneurs, venture capital firms, academic institutions, incubators, company creation platforms, and innovation ecosystems. Monitor emerging scientific, clinical, competitive, and investment trends across biotechnology, life sciences, AI-enabled drug discovery, and healthcare technology. Perform scientific, strategic, commercial, competitive, and financial due diligence on prospective investments. Transaction Execution Support the execution of venture investments, including direct equity investments, syndicate financing, company creation opportunities, and limited partner fund investments. Participate in transaction structuring, valuation analysis, term sheet review, and investment documentation alongside Legal and Finance partners. Prepare investment recommendations and present analyses to Amgen Ventures/Business Development leadership and governance committees. Portfolio Management & Strategic Engagement Support management of existing portfolio companies and fund relationships. Serve as a strategic liaison between portfolio companies and relevant stakeholders across Amgen. Assist with board observer responsibilities, portfolio monitoring, investment updates, and strategic follow-up. Identify opportunities for scientific collaboration, business development engagement, and strategic partnerships between Amgen and portfolio companies. Cross-Functional Leadership Collaborate closely with Research, Business Development, Strategy, Corporate Finance, Legal, and other cross-functional partners. Build strong internal networks to facilitate scientific evaluation and strategic engagement around investment opportunities. Contribute to portfolio reviews and leadership reporting,